About FOXG1 Syndrome
FOXG1 syndrome is caused by mutations or deletions in FOXG1 encoding forkhead box G1, a transcriptional repressor essential for brain development. Clinical features include congenital or early-onset microcephaly, severe intellectual disability, absent speech, stereotyped hand movements, dyskinesias, and seizures. Unlike classic Rett syndrome, FOXG1 syndrome has an earlier onset and more severe phenotype due to FOXG1's critical role in forebrain development rather than synaptic maintenance.
Common Clinical Features
Clinical Trial Eligibility Tips
What to know before applying to FOXG1 Syndrome trials.
FOXG1 pathogenic variant (deletion via array CGH or point mutation by sequencing) must be confirmed for all trials
Brain MRI showing simplified gyral pattern, corpus callosum hypoplasia, or delayed myelination is characteristic — provide imaging documentation
Movement disorder assessment (dyskinesia type, frequency, severity) is a distinct outcome measure from seizure frequency
FOXG1 is distinct from MECP2-related Rett syndrome — genetic confirmation avoids misclassification in Rett-specific trials
Patient Resources
Find recruiting FOXG1 Syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for FOXG1 Syndrome. Updated daily.